Prevnar 13® Pneumonia Vaccine Indicated for People 6 Weeks Through 5 Years of Age and for People 50 Years of Age and Older Pneumococcal 13-valent Conjugate Vaccine , Preservative Free 2.2 mcg - 4.4 mcg / 0.5 mL Injection Pr

Features

• In children 6 weeks through 5 years of age
• Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1
• 3
• 4
• 5
• 6A
• 6B
• 7F
• 9V
• 14
• 18C
• 19A
• 19F and 23F In children Prevnar is also indicated for active immunization for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4
• 6B
• 9V
• 14
• 18C
• 19F
• and 23F No otitis media efficacy data are available for serotypes 1
• 3
• 5
• 6A
• 7F
• and 19A In children 6 years through 17 years of age Prevnar 13 is indicated for active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1
• 3
• 4
• 5
• 6A
• 6B
• 7F
• 9V
• 14
• 18C
• 19A
• 19F and 23F In adults 50 and older
• Prevnar 13 is indicated for the active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1
• 3
• 4
• 5
• 6A
• 6B
• 7F
• 9V
• 14
• 18C
• 19A
• 19F and 23F The tip cap and rubber plunger of the prefilled syringe do not contain latex Store Refrigerated at 2° to 8°C (36° to 46°F)